Wellesley, MA, United States of America

Paul Nioi

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Paul Nioi

Introduction

Paul Nioi is a notable inventor based in Wellesley, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic methods for cardiovascular diseases. With a total of 3 patents, Nioi's work has the potential to impact patient care and treatment options.

Latest Patents

Nioi's latest patents focus on anti-ASGR-1 monoclonal inhibitory antibodies. These patents describe antigen binding proteins that interact with ASGR, ASGR-1, and/or ASGR-2. They also outline methods for making and using these proteins. Furthermore, his patents include methods for treating and preventing cardiovascular disease by administering a pharmaceutically effective amount of ASGR, ASGR-1, and/or ASGR-2 antigen binding proteins. Additionally, he has developed methods involving interfering RNA compositions that reduce the expression of ASGR, ASGR-1, and/or ASGR-2.

Career Highlights

Nioi is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions for complex health issues. His research has contributed to the understanding and treatment of cardiovascular diseases, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Nioi has collaborated with esteemed colleagues such as Peter Coward and Christopher Murawsky. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Paul Nioi's contributions to the field of biomedical research, particularly in cardiovascular disease treatment, highlight his role as a significant inventor. His patents and collaborations reflect a dedication to improving health outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…